Catalyst Wire Dossier Catalyst Wire Dossier

13-valent pneumococcal conjugate vaccine

13-valent pneumococcal conjugate vaccine · Sinovac Life Sciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for 13-valent pneumococcal conjugate vaccine, covering 2011-05-12 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China [Phase 3]

See pricing